Racer_X
Contributor
- Messages
- 80
- Reaction score
- 27
I recently had this conversation with my doctor. He waited a number of years before prescribing it to patients, including those that were diabetic and pre-diabetic while he reviewed case histories and studies. About 4 years in he began supporting it.
He's seen tremendous positive results that far outweigh the potential side effects. Specifically: blood pressure improvements, cholesterol improvements, and heart improvements - the three big killers that aren't cancer yet are weight related. Not to mention the benefits it delivers to diabetic patients are the SAME that prevent people from becoming diabetic in the first place, leading to better life expectancy.
Ancillary benefits include cravings management - for example one of his patients struggled with alcoholism, going to the ER and requiring hospitalization for alcohol imbibing issues at a rate in excess of once a month. Since going on the drug, this patient has stopped drinking entirely.
Finally, there's also a long term (multi-year) taper plan that can be implemented. This requires a lot of effort and attention to manage. However, I'm aware of at least one patient that has managed to reduce from 15 weekly to 7.5 doses every 12 days without a spike in morbidity conditions.
It's popular because it's right. Ibuprofen is popular because it's better than aspirin and Tylenol for pain management. Scuba gear is popular because it's hard to dive to 100 feet by holding your breath.
If you're going to say "what is popular is not always right" - yeah, that true. But it's also true that what is popular is not always wrong, either. So it's meaningless without data behind it.
He's seen tremendous positive results that far outweigh the potential side effects. Specifically: blood pressure improvements, cholesterol improvements, and heart improvements - the three big killers that aren't cancer yet are weight related. Not to mention the benefits it delivers to diabetic patients are the SAME that prevent people from becoming diabetic in the first place, leading to better life expectancy.
Ancillary benefits include cravings management - for example one of his patients struggled with alcoholism, going to the ER and requiring hospitalization for alcohol imbibing issues at a rate in excess of once a month. Since going on the drug, this patient has stopped drinking entirely.
Finally, there's also a long term (multi-year) taper plan that can be implemented. This requires a lot of effort and attention to manage. However, I'm aware of at least one patient that has managed to reduce from 15 weekly to 7.5 doses every 12 days without a spike in morbidity conditions.
It's popular because it's right. Ibuprofen is popular because it's better than aspirin and Tylenol for pain management. Scuba gear is popular because it's hard to dive to 100 feet by holding your breath.
If you're going to say "what is popular is not always right" - yeah, that true. But it's also true that what is popular is not always wrong, either. So it's meaningless without data behind it.